Which PrEP: Elopre and Farley
Answering the Questions on Which HIV PrEP for Which Patient: Latesha Elopre and Jason Farley

Released: July 03, 2023

Latesha Elopre
Latesha Elopre, MD, MSPH
Jason E. Farley
Jason E. Farley, PhD, MPH, ANP-BC, FAAN, AACRN

Activity

Progress
1
Course Completed

In this episode, Latesha Elopre, MD, MSPH, and Jason Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN, answer questions about HIV PrEP including:
•    How long someone can receive PrEP and the monitoring that is needed over time
•    Recommendations for monitoring bone health while receiving oral PrEP
•    Treatment as prevention and PrEP efficacy data and options for people who inject drugs
•    The role of circumcision in HIV prevention
•    The use of PrEP in pregnancy
•    Concern for ART resistance if someone seroconverts while receiving PrEP, especially when using nondaily PrEP options
•    The possibility of using FTC/TAF on demand
•    Inequities in adherence and persistence
•    Cost considerations with different PrEP modalities
•    Recommendations for hospitalized patients receiving PrEP
•    PrEP considerations for patients with renal dysfunction and higher BMIs
•    PrEP efficacy based on site of exposure